Compare2 funds · 1 pair
Picked · 2YTD
Close to theseFee · YTD
Best of the twoNov 5
  • Lowest cost$ a year on $10kXLK 0.08%
  • Most incometrailing 12-month yieldBBC 1.61%
  • Best 5 yearsper yearXLK +15.9%
  • Smallest drop · 1Yworst fall in the past yearXLK −19.6%
Measures won2–4XLK wins · of 6 · 5Y
$10,000 · 5Y$20,952XLK · BBC $9,380
Lowest cost0.08%XLK · $8 on $10k
Most income1.61%BBC · $161 on $10k
Smallest drop−19.6%XLK · worst fall in 1Y
Held in common0.0%BBC and XLK

BBC vs XLK

5Y
BBC
XLK
Virtus Biotech Clinical Trials ETF · $34MState Street Technology Select Sector SPDR ETF · $117B
+33.0%3 years · per year$23,503 · $20,176+26.4%
−1.3%5 years · per year$9,380 · $20,952+15.9%
0.65%Expense ratio$65 · $8 on $10k · lower wins0.08%
1.61%12-mo yield$161 · $51 on $10k0.51%
−30.2%Worst dropSmaller wins−19.6%
38.2%VolatilityLower wins28.5%
2–4XLK wins
$10,000 · 5 yearsOne scale
$10k startXLK $21.0kBBC $9.4kOct 2021Nov 2026
Shared top holdingsBBC · XLK

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 5, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BXLKState Street Technology Select Sector SPDR ETFReadDesk0.08%0.51%−8.0%+13.2%+11.1%+26.4%+15.9%−19.6%$117.1B
2ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.61%−6.6%+5.6%+36.3%+33.0%−1.3%−30.2%$34M
End-of-day Nov 5, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs XLK

5Y
Virtus Biotech Clinical Trials
$9,381
Technology Select Sector SPDR
$20,952
$10k$20kNov 2021Nov 2026$9,381$20,952$10k$20kNov 2021Nov 2026$9,381$20,952
MeasureBBCXLK
Fee0.65%0.08%
Cost on $10k a year$65$8
Yield1.61%0.51%
5 years, per year−1.3%+15.9%
3 years, per year+33.0%+26.4%
Worst drop · 1Y−30.2%−19.6%
Volatility · 1Y38.2%28.5%
4–2measures won
XLK first
0.0%
holdings shared
Nov 5, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

XLK vs VGT

YTD
SPDRXLK
+13.2%
VGTVanguard
+14.0%
Jan 1Nov 5+13.2%+14.0%
+13.2%Year to date+14.0%
0.08% · $8Fee · on $10k a year0.09% · $9
$117BAssets$155B
1–1level
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+32.3%
VIGVanguard
+12.5%
Jan 1Nov 5+32.3%+12.5%
+32.3%Year to date+12.5%
3.0%Yield1.5%
$123BAssets$109B
2–0SCHD wins
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+8.5%
JEPIJ.P. Morgan
+5.2%
Jan 1Nov 5+8.5%+5.2%
+8.5%Year to date+5.2%
12.2%Yield8.1%
$42.1BAssets$46.1B
2–0JEPQ wins
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, XLK

Today
0.0%most shared, BBC and XLK
BBCXLK
BBC—0.0%
XLK0.0%—
End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$96most kept, BBC
BBC$161 − $65 = $96
XLK$51 − $8 = $43
KeptFee
End-of-day Nov 5, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com